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Background: Copper is essential for the survival of aerobic organisms. If copper is not properly regulated in the
body however, it can be extremely cytotoxic and genetic mutations that compromise copper homeostasis result in
severe clinical phenotypes. Understanding how cells maintain optimal copper levels is therefore highly relevant to
human health.
Results: We found that addition of copper (Cu) to culture medium leads to increased respiratory growth of yeast, a
phenotype which we then systematically and quantitatively measured in 5050 homozygous diploid deletion strains.
Cu’s positive effect on respiratory growth was quantitatively reduced in deletion strains representing 73 different
genes, the function of which identify increased iron uptake as a cause of the increase in growth rate. Conversely,
these effects were enhanced in strains representing 93 genes. Many of these strains exhibited respiratory defects
that were specifically rescued by supplementing the growth medium with Cu. Among the genes identified are
known and direct regulators of copper homeostasis, genes required to maintain low vacuolar pH, and genes where
evidence supporting a functional link with Cu has been heretofore lacking. Roughly half of the genes are conserved
in man, and several of these are associated with Mendelian disorders, including the Cu-imbalance syndromes
Menkes and Wilson’s disease. We additionally demonstrate that pharmacological agents, including the approved
drug disulfiram, can rescue Cu-deficiencies of both environmental and genetic origin.
Conclusions: A functional screen in yeast has expanded the list of genes required for Cu-dependent fitness, revealing
a complex cellular system with implications for human health. Respiratory fitness defects arising from perturbations in
this system can be corrected with pharmacological agents that increase intracellular copper concentrations.
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Copper is an essential element for most living organ-
isms. Its incorporation into specific enzymes is required
for catalysis of several vital, and highly conserved cellu-
lar processes [1]. For example, copper binding to specific
sites in cytochrome c oxidase (i.e. complex IV of the
electron transport chain) is required for complex assem-
bly and stability, electron transfer activity, and ultimately
respiratory metabolism [2]. Copper metallation also has
important roles in responding to oxidative stress, by* Correspondence: bstonge@stanford.edu
Stanford Genome Technology Center, Department of Biochemistry,
Stanford University, 855 S California Avenue, Palo Alto, CA 94304, USA
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reproduction in any medium, provided the oractivating superoxide dismutase (SOD1) [3,4], and in
regulating iron import by activating ferroxidases, which
oxidize substrates for iron transporters [5-7].
The unique redox chemistry of copper ions, which al-
lows it to exist in an oxidized (Cu2+) or reduced (Cu1+)
state, is key to its catalytic properties but also contrib-
utes to its production of reactive oxygen species (ROS).
To keep this deleterious capacity in check, the cell has
evolved mechanisms to maintain tight regulatory control
of copper storage and transport [1]. Metallochaperones
protect the cell from copper toxicity by binding to free
copper and facilitating its transport to, and incorporation
into, important target proteins [8]. The yeast cytosolicl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ATPase, which transports copper into the Golgi where
it activates the Fet3 ferrooxidase, ultimately leading to
iron uptake.
The importance of maintaining proper copper homeo-
stasis is underscored by several rare, yet severe, genetic
diseases. Wilson’s disease is an autosomal recessive dis-
order resulting from mutations in the copper transporter
ATP7B, the human ortholog of yeast CCC2. Patients ex-
press a variety of neurological, psychiatric, and hepatic
problems arising from abnormal copper accumulation,
primarily in the brain and liver [9]. Mutations in the re-
lated gene ATP7A cause the X-linked recessive disorder
Menkes disease [10]. Notably, the clinical symptoms of this
disease arise from copper deficiency, and include neuro-
logical defects (mental retardation, seizures), growth re-
tardation, hypothermia and “kinky” or “steely” hair [11].
Mitochondrial complex IV disorders, including Leigh syn-
drome, have also been linked to genes with important roles
in copper metabolism, including SCO1, SCO2, and SURF-
1 [12-19]. Abnormal copper concentrations have also been
observed in Alzheimer’s and Huntington’s disease [20-22],
and copper has been shown to promote aggregation of the
α-synuclein protein, a hallmark of Parkinson’s disease [23].
Yeast has been an exceptionally useful model organism
for deciphering the cellular mechanisms regulating cop-
per homeostasis [24,25], and indeed yeast orthologs exist
for most of the disease genes described above. Here, we
leverage the dependency between respiratory growth rate
and copper availability to conduct a systematic screen for
genes associated with copper homeostasis. This screen
identified genes with known roles in copper regulation,
and those with no previously identified functional associ-
ation with copper. Consistent with the vacuole being a cel-
lular store for copper, many of the genes identified are
required for vacuole acidification, and we go on to show
that copper is in fact limiting under conditions of vacuole
stress. Several genes were also orthologs of human disease
genes that have not been previously linked to copper im-
balance. Finally, we demonstrate that the approved drug
disulfiram (DSF), and the experimental drug elesclomol
(ES), can rescue respiratory growth defects arising from
copper deficiency.
Results and discussion
Respiratory fitness and copper
Though yeast preferentially ferment glucose for energy,
they are able to switch to oxidative phosphorylation in
the absence of a fermentable carbon source [26,27]. This
attribute, in addition to its simple growth requirements,
makes yeast a powerful model system for identifying chem-
ical probes targeting energy metabolism [28]. To identify
chemical compounds that ‘boost’ respiratory growth, and
potentially serve as leads for human mitochondrial diseases,we conducted a phenotypic screen of ~3000 natural prod-
uct derivatives (TimTec) for compounds that accelerated
growth of respiring yeast (grown in Yeast Extract, Peptone,
Ethanol, Glycerol medium; YPEG), but not fermenting
yeast (grown in Yeast Extract, Peptone, Dextrose medium;
YPD). This screen identified a series of structurally related
compounds with the desired effect, but we determined that
this effect was attributed to the CuCl2 salt with which
each compound was supplied (Additional file 1: Figure
S1A and S1B).
To further examine the effect of copper ions on re-
spiratory growth, yeast (BY4743) was grown in YP media
containing the non-fermentable carbon source ethanol
(YPE), at various concentrations of copper sulfate (CuSO4).
Growth of 100 μl cultures was monitored in 96well plates
by measuring the increase in absorbance over time (see
Methods). Supplemental copper concentrations as low as
10 nM were found to boost growth (Figure 1A and B). This
boost was dose-dependent, but plateaued at 2 μM, indicat-
ing a saturation of copper above this concentration. In con-
trast, no such boost was observed in dextrose-containing
media (YPD) (Figure 1B). This positive effect of Cu was
further confirmed to be specific to respiratory growth
conditions by comparing growth in other fermentable
(galactose) and non-fermentable (glycerol and lactate)
carbon sources (Additional file 1: Figure S1C). Similar
results were obtained using spot assays on agar plates.
When respiring yeast were pre-grown in the presence of
copper-supplemented media, no significant increase in
the number of colony forming units was observed, how-
ever, the size of each colony was substantially increased
(Additional file 1: Figure S1D). From this we conclude
that copper (at the concentration tested) does not dra-
matically influence yeast viability, but rather, increases
growth under respiratory conditions.
We also tested the effect of copper depletion on respira-
tory growth, by culturing yeast in increasing concentra-
tions (1 – 1000 μM) of the copper chelator, bathocuproine
disulphonic acid (BCS). A significant dose-dependent re-
duction in growth was observed at BCS concentrations as
low as 1 μM, and growth was strongly inhibited at BCS
concentrations higher than 100 μM (Figure 1A and C).
This inhibitory effect, however, was attenuated by addition
of CuSO4 to the growth medium (Figure 1A). For example,
the addition of 500 μM CuSO4 completely suppressed the
inhibitory effects of BCS. Similar experiments using YPD
media showed that addition of BCS does not alter fermen-
tative growth (Figure 1C). Collectively, these results dem-
onstrate a critical dependency between respiratory growth
and copper ion concentrations in the growth medium.
A screen for copper homeostasis genes
To better understand the underlying cellular mechanisms











































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1 Media copper concentrations influence respiratory, but not fermentative, growth in yeast. (A) Dose–response matrix measuring
the combinatorial effects of copper sulfate (CuSO4) and bathocuproine disulphonic acid (BCS, a copper chelator) on respiratory growth. Yeast
(BY4743) was grown under respiring conditions (YPE media) in increasing concentrations of CuSO4 (see right) and BCS (see top). Optical density
(i.e. OD600, y-axis) of each culture is plotted over time (x-axis). Each condition is colored based on growth relative to the untreated condition
(i.e. no BCS and no CuSO4 added; marked with an asterisk and represented by the grey curve). Green and red indicate increased and decreased
growth relative to this reference, respectively (see legend below). Growth data highlighted in yellow and blue were used in (B) and (C), respectively.
(B) Dose–response curves illustrating the effect of CuSO4 (x-axis) on yeast growth. Growth relative to that in the absence of CuSO4 is plotted on the
y-axis, and was measured in both fermenting (YPD) and respiring (YPE) conditions (indicated in black and red, respectively). The mean of three
replicates is plotted; error bars represent the standard deviation. (C) Similar to (B) but measuring the effects of BCS (x-axis).
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individual diploid strains have both copies of a non-
essential gene deleted. This collection has been a valuable
resource for genome-scale analysis of conditions affecting
growth [29-31]. Each strain contains unique 20-bp “bar-
code” sequences flanked by common priming sites, allow-
ing the relative abundance of individual strains to be
quantitatively monitored within a pool of competitively-
grown strains [32,33]. Previous work has used this resource
to identify genes that protect fermenting yeast from toxic
concentrations of copper [34]. To identify genes that are
important for Cu-dependent respiratory growth, we mea-
sured the fitness of 5050 homozygous deletion strains
(Additional file 2: Table S1) in parallel in rich media (i.e.
Yeast Extract, Peptone) using dextrose, ethanol, glycerol,
or lactate as a carbon source, in the presence or absence of
500 μM CuSO4 (a concentration that increases respiratorygrowth rate of the parental strain). Each condition was
tested in triplicate. CEL files are available via the NCBI's
Gene Expression Omnibus [35] under accession number
GSE47175. Though it was not a goal of this study, examin-
ation of this dataset reveals genes that are specifically re-
quired for metabolizing different non-fermentable carbon
sources. For example, the fsh1Δ/fsh1Δ deletion strain
showed an ethanol-specific growth defect (Additional file 1:
Figure S2). This suggests a role for FSH1, a putative
serine hydrolase that has sequence-similarity to the hu-
man candidate tumor suppressor OVCA2 [36,37], in
ethanol metabolism.
Importantly, these experiments identified a group of 313
respiratory-deficient strains (see Methods and Additional
file 2: Table S1) that grew in YPD but were undetect-
able following competitive growth in media using non-
fermentable carbon sources. As expected, the majority
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in a screen for mutants with impaired mitochondrial
respiration [31]. Genes deleted in these strains were also
enriched for the biological processes mitochondrion
organization (p-value: 1.44e-99) and cellular respiration
(p-value: 2.03e-22). We reasoned that the inability of these
strains to compete with respiratory-proficient strains in
our competitive assay may preclude accurate measure-
ment of their response to Cu. Therefore, to better assay
these strains, we assembled a smaller pool consisting only
of these 313 strains, plus an additional 18 strains of inter-
est (see Material and Methods), and interrogated this pool
in YPE, in the presence or absence of 500 μM CuSO4.
The effect of CuSO4 on the collective growth of the pools
was similar to that observed for BY4743 in Figure 1. To
identify individual strains where this effect was altered, we
compared the abundance of each barcode in the copper-
treated samples to untreated samples, for both deletion
pools, and for each non-fermentable carbon source (see
Figure 2A). Using a stringent cutoff (log2 fold change > 1.5
and q-value < 0.05; see Methods), we identified 79 deletion
strains in which Cu’s positive effect on respiratory growth
was quantitatively reduced, and 105 strains in which Cu’s
positive effects were substantively greater (compared to
other strains in the pool) in at least one non-fermentable
carbon source (Additional file 2: Table S1 and Additional
file 1: Figure S3 and S4). The latter set was largely com-
prised of strains with respiratory growth defects that were
specifically rescued by the addition of CuSO4. However, the
majority of strains with respiratory growth defects were not
substantively aided by the addition of CuSO4 (Additional
file 1: Figure S5), underscoring that the copper-rescue effect
was specific to the 105 strains identified.
We applied hierarchical clustering to the Cu-induced
fitness changes observed in each of the four carbon sources
for these 184 strains (Figure 2B). An examination of the
clusters across the experiment axis showed that all repli-
cate experiments correlated as nearest neighbors, confirm-
ing that the genome-wide data were highly reproducible.
Samples grown in YPD clustered separately from the non-
fermentable (YPE, YPG, and YPL) carbon-sources and in
YPD, the fitness of most of these strains was not greatly af-
fected by the addition of CuSO4. This is consistent with
copper affecting respiratory, but not fermentative growth
at the concentration tested. While the results were gen-
erally consistent between the non-fermentable carbon
sources, carbon source-specific effects were apparent as
well. Most notably, growth in lactate identified many
more strains exhibiting an increased Cu boost than did
growth in ethanol or glycerol. This difference may be
attributed to the higher respiratory fitness of many
strains in YPL (due to the lower pH of this media; dis-
cussed further below) which facilitates their detection
in our competitive assay. While this explanation attributescarbon-source specific results to technical limitations of
the competitive growth assay (i.e. slow growing strains
dropping out of the pool in YPE and YPG, but not YPL),
it is also possible that mechanistic differences in the catab-
olism of ethanol, glycerol, and lactate result in discrete
genetic dependencies for the copper response. Further ex-
perimentation will be needed to determine whether such
cases do indeed exist.
To search for functional enrichment among the genes
that were deleted in the 105 and 79 strains identified
above, we used the Biological Networks Gene Ontology
plugin (BiNGO) for Cytoscape (see Methods). The two
gene lists contained 11 and 6 ‘dubious’ open-reading
frames, respectively, that partially overlapped with a veri-
fied gene. In several instances these strains confirmed
the results for verified genes (such as the dubious ORFs
YDR203W and YDR455C which overlap with RAV2 and
NHX1, respectively). One gene, ADA2, was represented
twice in the deletion pool and both strains were identi-
fied in our screen. For our Gene Ontology (GO) analysis
we used the non-redundant set of genes. The 73 genes
that were required for Cu-dependent growth (i.e. whose
deletion diminished the Cu-dependent growth boost),
were significantly enriched for several GO categories, in-
cluding 2-oxoglutarate metabolic process, and iron ion
homeostasis (Additional file 1: Figure S6 and Additional
file 2: Table S2). Among the genes belonging to the latter
term is FET3, which encodes the high-affinity iron up-
take protein that links iron and copper homeostasis [39].
The dependence of copper’s effects on Fet3 was verified
in isogenic cultures, and in fact, the fet3Δ/fet3Δ strain
exhibited reduced (not enhanced) growth in 500 μM
CuSO4 (Additional file 1: Figure S7A). Copper-limiting con-
ditions are known to result in cellular iron deficiency
[24,40], and we found that addition of high concentrations
of FeSO4 was itself sufficient to enhance respiratory growth
of yeast (Additional file 1: Figure S7B). Therefore, to further
explore the role of iron, we repeated the experiment de-
scribed in Figure 1A in the presence of excess FeSO4.
Addition of 1 mM FeSO4 was found to confer resistance to
low concentrations (≤10 μM) of BCS, and to effectively
mask the growth advantages imparted by CuSO4 under
these conditions (Additional file 1: Figure S7C). Collect-
ively, these data suggest that increased iron uptake contrib-
utes to the respiratory growth increase arising from copper
supplementation.
In contrast, the 93 genes in the enhanced growth group
were significantly enriched for the GO processes Golgi to
vacuole transport and vacuolar acidification (Figure 2C,
Additional file 1: Figure S6 and Additional file 2: Table S3).
Among this list of 93 genes are three genes that are directly
linked to copper transport in yeast (CTR1, ATX1 and
CCC2) and in higher eukaryotes (hCTR1/2, Atox1 and













































































































Figure 2 A systematic screen for genes involved in Cu-dependent growth. (A) Schematic of the experimental workflow. A complete pool of
homozygous deletion mutants and a smaller pool of respiration deficient strains (see Methods) were grown under respiratory conditions in the
presence and absence of CuSO4. Comparison of CuSO4-treated and -untreated samples, identified 105 and 79 strains where Cu’s effect on growth
was increased or decreased, respectively (see Methods). (B) Heatmap depicting log2 ratios of CuSO4-treated and -untreated samples (see legend
below) for the 184 strains identified in (A). Yellow indicates greater Cu-dependent growth and blue indicates reduced Cu-dependent growth.
Dendrograms depict the results from hierarchical clustering of genes (y-axis) and experiments (x-axis). (C) Network illustrating overrepresented
Gene Ontology categories (nodes) among the 105 strains with an enhanced response to copper. This gene list was analyzed, and the network
image created, using the BiNGO plugin for Cytoscape [38] (see Methods). Representative nodes are circled and labelled with those genes identified in
the screen. (D) Dotplots of log2-transformed microarray fluorescence intensities for a select set of deletion strains. Triplicate data points for YPD and
the non-fermentable carbon source in which the greatest copper response was observed are shown for copper-treated (green) and -untreated (blue)
conditions. YPE, YPG, and YPL refer to data from the complete homozygous deletion pool experiment; YPE* refers to the respiration defective pool.
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cytosolic copper metallochaperone Atx1 transports Cu
ions from the high-affinity copper transporter Ctr1 in the
plasma membrane to Ccc2 on post-Golgi vesicles to even-
tually target it to Fet3 on the cell surface [6,7,41,42]. Our
screen also identified GEF1, a chloride channel involved incation homeostasis. The Gef1 protein co-localizes with
Ccc2 at late- and post-Golgi vesicles and is required for
loading Cu ions onto Fet3 [43]. For other genes identified
by our screen, evidence supporting a functional role in cel-
lular copper homeostasis is either limited or lacking en-
tirely. These include YPL109C, which encodes a protein of
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mitochondria [44,45]. Figure 2D shows quantile-normalized
fluorescence values for several of the deletion strains spe-
cifically discussed herein. The complete results for all
strains identified in our screen are shown in Additional
file 1: Figure S3 and S4. Collectively, these data will be a
rich source of information for future characterization of
genes involved in copper homeostasis.
Previous work in yeast has demonstrated that mito-
chondria maintain a non-proteinaceous copper pool that
exceeds CcO-associated copper concentrations [46]. It is
thought that this pool may serve as a source of copper
ions for chaperones that mediate metallation of CcO,
which occurs at two CcO subunits encoded by the mito-
chondrial genome, Cox1 and Cox2 [8]. The metallocha-
perone Cox17 transfers copper to two mitochondrial
inner membrane proteins Cox11 and Sco1 [47], which
then mediate metallation of Cox1 and Cox2, respectively
[8]. It is notable that our genomic screen did not identify
the cox17, cox11, or sco1 deletion strains as being res-
cued by copper. These results are consistent with previ-
ous analysis of sco1 null strains [48], and of cox17 null
strains, whose respiratory growth defect was rescued by
copper, but only at concentrations much higher than
those used in the present study [49].
Vacuole acidity and copper homeostasis
The yeast vacuole, generally regarded as the functional
equivalent of the mammalian lysosome, is an acidic or-
ganelle with a variety of important functions including:
protein degradation, ion and small-molecule storage,
and pH homeostasis [50,51]. Consistent with previous
work demonstrating an important role for the vacuole in
storage and mobilization of Cu ions [1,52-54], several
genes that maintain vacuolar pH, when deleted, were
found to produce respiratory growth defects that were
rescued by copper. These included numerous subunits of
the vacuolar H+−ATPase (such as VMA1, VMA2, VMA3,
VMA4, VMA6, VMA7, VMA11, VMA13, VMA16, and
STV1) and 2 subunits of the RAVE complex (RAV1 and
RAV2) which promotes assembly of the V-ATPase holoen-
zyme. Mobilization of vacuolar copper is thought to in-
volve the Ctr2 protein, a copper transporter that localizes
to the vacuolar membranes of budding yeast [52,53], fis-
sion yeast [55], and mammalian cells [56]. Though a ctr2Δ
mutant was not included in our deletion collection and
thus not identified in our screen, we did identify the CTR2-
regulating transcription factors AFT1 andMAC1 [57].
These results suggest that the pH gradient across the
vacuolar membrane plays a critical role in maintaining
optimal copper homeostasis. We therefore examined the
effects of increasing media pH on the cellular response
to copper (Figure 3A). Because alkaline growth conditions
increase vacuolar pH more than cytosolic pH [58,59], theyeffectively reduce the pH gradient between the two cellu-
lar compartments. Consistent with previous findings on
dextrose-containing media [60], we find that respiratory
growth impairment by alkaline stress, is largely alleviated
by supplementing the growth medium with CuSO4
(Figure 3A and B). To more directly assess the role of
vacuole acidity on copper homeostasis, we applied the
small molecule Bafilomycin A1 (BafA), a natural prod-
uct derived from Streptomyces griseus that specifically in-
hibits vacuolar H+−ATPase [61]. BafA strongly inhibited
growth of respiring yeast at sub-micromolar concentra-
tions however this inhibition could be suppressed by sup-
plementing the media with CuSO4 (Figure 3C and D).
These data further establish an important role for the
vacuole in controlling cellular copper homeostasis, and
moreover identify copper as a major limiting factor under
vacuolar stress conditions. Notably, addition of high con-
centrations of FeSO4 also partially suppressed growth in-
hibition by BafA and masked the effects of CuSO4 under
these conditions (Additional file 1: Figure S7D). This is
consistent with Cu-limitation arising from vacuole de-
acidification causing a cellular iron deficiency that nega-
tively impacts growth.
Human disease genes
Our functional screen was highly sensitive in detecting
small Cu-dependent changes in cell fitness. Mutations in
non-essential genes that yield subtle phenotypes may be
more likely to cause disease, compared to for example,
genes required for viability. Therefore, we next examined
the genes we identified for sequence homology to hu-
man genes associated with disease (see Additional file 2:
Table S4 for complete results). Table 1 lists those human
disease genes with yeast orthologs, that when deleted,
yield respiratory fitness-defects that are rescued by cop-
per supplementation. The diseases associated with these
genes include Menkes and Wilson’s disease, both of which
are caused by mutations in genes orthologous to yeast
CCC2, and both of which are well established Cu-related
disorders [9,11]. The other diseases in Table 1, typically
present with neurologic, musculoskeletal and hematologic
features, which show remarkable similarities to clinical
phenotypes seen in patients with Menkes' copper defi-
ciency [11]. Many of these disease genes have a role in
intracellular trafficking, including several members of
the AP-1 adaptor complex, an important component of
clathrin-coated vesicles [62]. Interestingly, a combined
zebrafish/yeast chemical-genetic screen has also identi-
fied this complex as having a conserved role in buffering
the effects of copper limitation [63]. Knock-down experi-
ments in human cell lines will determine whether these
genes fulfill a similar function in man, and may prompt a
closer examination of whether copper plays a role in the
disorders listed in Table 1.
Figure 3 Vacuolar pH plays a critical role in maintaining copper homeostasis. (A) Dose–response matrix measuring the combinatorial effects of
CuSO4 and media pH on respiratory growth. BY4743 was grown in buffered YPE media of increasing pH (see top), in multiple concentrations of CuSO4
(see right). Optical density (i.e. OD600, y-axis) of each culture is plotted over time (x-axis). Samples are color-coded according to growth relative to that
in pH 4.5 for each copper concentration (see asterisks and grey curves). Data in blue and yellow boxes were used for the dose–response curve in B.
(B) Dose–response curves measuring the effect of increasing media pH (indicated on x-axis) on respiratory growth in the presence (red) or absence
(black) of 1333 μM CuSO4. Growth relative to that in pH 4.5 is plotted on the y-axis. The mean of three replicates is plotted; error bars represent the
standard deviation. (C and D) as in (A and B), only examining the combinatorial effects of CuSO4 and bafilomycin A1 (a specific inhibitor of vacuolar
H+−ATPase) on growth in unbuffered YPE media.
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Pharmacological modulation of Cu homeostasis is an at-
tractive therapeutic strategy for a variety of clinical applica-
tions. Copper chelating agents are currently the standard
treatment to ameliorate copper overloading of affected tis-
sues in Wilson’s disease [11], whereas early treatment of
Menkes disease with copper has shown some promise in
newborns having mutations that do not completely abro-
gate ATP7A [65]. Recent work in model systems has also
demonstrated that host cell copper metabolism influences
RNA virus replication [66], and leveraging copper’s cyto-
toxic properties is also being explored for cancer therapy,
and may be effective in targeted killing of tumor cells
[67-72].
The ability of several compounds to increase copper
concentrations in different cellular compartments was re-
cently characterized [67]. We examined the effects of two
of these compounds (disulfiram and elesclomol; Figure 4A),on respiratory growth in yeast. Consistent with our results
in Figure 1, and with their ability to increase intracellular
copper concentrations, both DSF and ES conferred sig-
nificant resistance to the copper chelating agent BCS
(Figure 4B). At the equivalent concentration (0.228 μM),
ES was more effective than DSF in rescuing BCS-induced
growth defects, an observation that is consistent with ES
having a stronger effect on intracellular copper concentra-
tions in human cell lines [67].
We next assessed the ability of DSF and ES to rescue
the effects of genetically-induced copper deprivation. Our
genomic screen identified the ctr1Δ/ctr1Δ strain, which
lacks the primary copper transporter in yeast [42], as be-
ing most aided by supplemental copper among the >5000
strains tested (Figure 2D and Additional file 2: Table S1).
We found that DSF rescued the severe respiratory defect
of this strain in a dose-dependent manner, with the
strongest effect observed at 0.468 μM DSF (Figure 4C).
Table 1 Human disease genes putatively associated with copper imbalance
Yeast gene Human gene % ident. Subcellular localization Biological function OMIM Clinical phenotype
CCC2 ATP7A 23 Golgi apparatus, Plasma membrane Cu ion transport across membranes 309400 Menkes disease (copper deficiency)
ATP7B 24 Golgi apparatus, Mitochondria 277900 Wilson disease (copper overload)
ADK1 AK2 54 Mitochondrial inter-membrane space Energy and nucleotide metabolism 267500 Immunodeficiency, sensorineural deafness
COX12 COX6B1 42 Energy metabolism, respiratory chain complex 220110 Encephalopathy, growth retardation, vision loss
VMA2 ATP6V1B1 73 Endomembrane, plasma membrane Vacuolar proton-translocating ATPase 267300 Renal tubular acidosis, sensorineural deafness
HFA1 ACACA 38 Mitochondria, cytoplasm Fatty acid biosynthesis 613933 Encephalopathy, growth retardation, myopathy
GEF1 CLCN5 30 Endosome membrane, lysosomal membrane Chloride channels and ion transporter 300009 Renal tubular disease,kidney stones
CLCN7 20 166600 Osteosclerosis, multiple fractures, vision loss
VPS33 VPS33B 23 Protein transport, membrane fusion 208085 Arthrogryposis, renal dysfunction, cholestasis
NHX1 SLC9A9 27 Endosome membrane pH regulation, ion transport 613410 Autism, seizures
SLC9A6 26 300243 Mental retardation, seizures, ataxia
APS1 AP1S2 51 Golgi apparatus AP-1 adaptor complex, protein
transport, vesicular trafficking
300630 Mental retardation, cerebral calcifications
AP4S1 26 614067 Spastic paraplegia, mental retardation
APL2 AP4B1 22 614066
APM1 AP4M1 24 612936
ARL1 ARL6 39 Protein transport, metal ion binding,
membrane trafficking
209900 Mental retardation, obesity, retinopathy
ARL3 ARL13B 13 612291 Cerebral malformation, mental retardation
COG6 COG6 19 Oligomeric Golgi complex, vesicular transport 606977 Vitamin K deficiency, intracranial bleedings
APL6 AP3B1 20 AP-3 adaptor complex, protein transport 608233 Platelet defect, albinism, immunodeficiency
ERG24 DHCR7 27 Endoplasmatic reticulum Cholesterol biosynthesis, sterol metabolism 270400 Mental retardation, congenital malformation
LBR 27 Nuclear membrane 215140 Skeletal dysplasia, leukocyte disorder
Twenty-one human disease genes which have a yeast orthologue (% identity of human protein in column 3) that, when deleted, produced a respiratory fitness defect that was specifically rescued by copper
supplementation. The gene products of the 21 disease genes have distinct functions and subcellular localizations [64], while mutations in these genes are typically associated with neurologic, musculoskeletal and
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Figure 4 Pharmacological rescue of Cu-deficiency phenotypes. (A) Chemical structure of disulfiram (DSF) and elesclomol (ES). (B) Dose–response
curves measuring the sensitivity of respiring yeast (BY4743 grown in YPE) to increasing concentrations of BCS (indicated on x-axis), in the presence of
0.228 μM DSF (black) or 0.228 μM ES (green). Growth relative to that in the absence of BCS is indicated by the y-axis. The mean of three replicates are
plotted; error bars indicate the standard deviation. (C) Respiratory growth of the ctr1Δ/ctr1Δ strain in response to various concentrations of DSF (indicated
on the x-axis). Growth after 40 hours in YPE was measured by area under the curve (y-axis). The mean of 3 replicates is plotted. Error bars indicate the
standard deviation. Representative growth curves are shown on the right. (D) Similar to (C) only involving ES.
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http://www.biomedcentral.com/1471-2164/15/263ES rescued growth of the ctr1Δ/ctr1Δ strain as well, and
did so over a much broader concentration range, and at
sub-nanomolar concentrations (Figure 4D). Comparable
to the effects of Cu, both drugs also increased respira-
tory growth of the parental BY4743 strain (Additional
file 1: Figure S8) suggesting that either drug could be used
to correct a range of Cu-deficiencies. It is noteworthy that
while DSF inhibited growth at higher concentrations, ES-
induced growth inhibition was dependent on supplement-
ing the media with Cu (Additional file 1: Figure S8), an
observation that is consistent with previous findings [72].
When tested against several strains listed in Table 1, moststrains were rescued by both ES and DSF, but interestingly,
neither drug rescued the respiratory growth defects of
the gef1Δ/gef1Δ or ccc2Δ/ccc2Δ strains (Additional file 1:
Figure S9), which lack genes specifically required for load-
ing Cu into Fet3. These data suggest that, unlike CuSO4
added to the growth media, DSF- and ES-delivered copper
require Gef1- and Ccc2-dependent Cu loading into Fet3
to confer enhanced growth.
ES is a promising anti-cancer agent that induces oxi-
dative stress in a copper-dependent manner [67,72]. DSF
has been used for the treatment of alcoholism for decades
[73] and confers therapeutic value by inhibiting aldehyde
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http://www.biomedcentral.com/1471-2164/15/263dehydrogenase (ALDH), which decreases the alcohol toler-
ance in patients [74]. DSF has also been shown to perturb
vacuolar pH in yeast, and inhibit V-ATPase activity in cell-
free assays [75]. Though our results clearly identify copper
homeostasis as a rate-limiting effect of these drugs on
respiratory growth, further experiments will be required
to determine their precise mechanism-of-action. Never-
theless, our data highlight the ability of copper ionophores
to potently and precisely tune cellular fitness under copper-
limiting conditions. Leveraging the pharmacological tract-
ability of copper homeostasis, though confronted with
inherent cytoxicity obstacles, may warrant exploration
as a therapeutic strategy for copper- or iron-deficiency
in man.
Conclusions
A systematic screen of the yeast deletion collection was
conducted to identify genes that have a role in Cu-
dependent respiratory fitness. The screen revealed a com-
plex cellular system involving many genes that were not
previously associated with copper homeostasis. The re-
sults are consistent with copper limitation producing a
secondary iron deficiency that negatively impacts respira-
tory growth, and with the vacuole playing a vital role in
regulating intracellular copper levels. Roughly half of the
genes identified in our screen are conserved in man, and
many of these are associated with Mendelian diseases,
underscoring the potential translation of our findings to
human health. Pharmacological agents that increase intra-
cellular copper concentrations can be effective in compen-
sating for perturbations in copper homeostasis.
Methods
Reagents
Copper (II) sulfate, tetraethylthiuram disulfide (disulfiram),
and bathocuproine disulfonic acid disodium salt (BCS) were
purchased from Sigma-Aldrich. Elesclomol was purchased
from Selleckchem and bafilomycin A1 was purchased from
Enzo Life Sciences. Copper (II) sulfate was dissolved in
water and stored at room temperature. BCS, elesclomol,
bafilomycin A1, and disulfiram were dissolved in DMSO,
aliquoted, and stored at −20°C until use. We used a HP
D300 Liquid Dispenser (Tecan) for all experiments involv-
ing DMSO-dissolved compounds.
Media and growth rate analysis
All media was prepared using deionized water. Rich media
(YP) consisted of 10 g yeast extract, 10 g bactopeptone
per liter. For Figure 3 A and B the YP media was buffered
with 25 mM HEPES and pH-balanced as indicated using
1 M NaOH or 12.1 M HCl, to raise or lower the pH, re-
spectively. 25 mM HEPES was also included in the media
used for Additional file 1: Figure S1, and we note that
addition of the HEPES buffer reduced the respiratorygrowth rate of yeast. All other experiments were per-
formed using YP media without HEPES. Pre-cultures of
the isogenic strains were grown overnight to saturation in
rich media supplemented with 2% dextrose. These cul-
tures were then used to inoculate YP media supplemented
with carbon sources at 2% as indicated in the Figure leg-
ends. Isogenic cultures (100 μl) were inoculated at a
concentration of 0.03 OD600/ml and grown in 96well
microtiter plates at 30°C. The plates were sealed with
adhesive plate seals (Thermo Scientific) and holes were
poked in the seal for every well using a 21 gauge needle to
allow sufficient aeration (cultures using non-fermentable
carbon sources only). Optical density was measured every
15 min over the course of several hours (as indicated in
graphs) using a GENios microplate reader (Tecan). The
growth rate of a strain was calculated as follows: 1) the
first 10 OD readings were averaged and subtracted from
all OD readings of the corresponding curve in order to set
the baseline of the growth curve to zero, 2) the area under
the curve (AUC) was then calculated as the sum of all OD
readings. In general, 50 and 100 reads (corresponding to
12.5 and 25 hours, respectively) were used for strains
grown in fermentative conditions (dextrose and galactose)
and in respiratory conditions (ethanol, glycerol, and lac-
tate), respectively. 160 reads (40 hours) was used for
Figures 4C and D (ctr1Δ/ctr1Δ). A “relative growth”
value was calculated as previously described [76], as
follows: (AUCcondition – AUCcontrol)/AUCcontrol; where
AUCcontrol represents the growth rate of the reference
condition (marked with an asterisk in all Figures) that
was assayed on the same microtiter plate.
Deletion pool construction and growth conditions
The homozygous deletion pool was constructed as de-
scribed [30] and stored in aliquots at −80°C. For all screen-
ing experiments, aliquots of the pool were thawed and
diluted in YP media plus a carbon source (2% of dextrose,
ethanol, glycerol or lactate) to a concentration of 0.04
OD600/ml. 700 μl of this cell suspension was then aliquoted
into every well of a 48well plate and copper sulfate was
then added (from an 500 mM stock solution in water) to a
final concentration of 500 μM. The plates were sealed with
adhesive plate seals and holes were poked for every well to
allow sufficient aeration. The plates were incubated at 30°C
with vigorous shaking and optical density was measured
every 15 min over the course of the experiment. Each
sample was grown for precisely 9 generations. Cells were
maintained in logarithmic phase by robotically diluting cul-
tures every three doublings using a Packard Multiprobe II
four-probe liquid-handling system (PerkinElmer, Wellesley,
California, United States). Experiments were performed
in triplicate. After reaching 9 pool generations 600 μl of
the cultures were harvested, pelleted by centrifugation
and snap frozen in liquid nitrogen. The pellets were kept
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ation, PCR, and microarray hybridization, see below).
To construct the pool of respiration deficient mutants
we first analyzed samples from the YPD, YPE, YPG, and
YPL experiments where no additional copper was added to
the media. Strains with a median of log2-transformed raw
fluorescence units < 7 in the combined YPE, YPG, and YPL
samples and a median of log2-transformed raw fluores-
cence units > 8 in the YPD samples were selected. This
identified 313 strains, to which we added an additional 18
strains of interest (Additional file 2: Table S1). The 331
strains were streaked from frozen stocks onto YPD agar
plates, grown for 3 days at 30°C, and then pooled and
stored in aliquots at −80°C. This pool was assayed as de-
scribed above for the complete homozygous deletion pool.
Genomic DNA preparation, PCR, and
microarray hybridization
Genomic DNA preparation, PCR amplification of molecu-
lar tags, and microarray hybridization were as described
[77]. Genomic DNA was extracted from cell pellets using
the YeaStar Genomic DNA kit from Zymo Research
(D2002). The relative abundance of each strain was then
assessed by amplifying and hybridizing their molecular
barcodes to a Genflex Tag 16 k array (Affymetrix).
Identification of strains exhibiting increased or decreased
Cu-dependent growth
To quantify Cu-dependent growth of each deletion strain,
we calculated a “Copper Response Score” (CRS) for each
strain in each of the four respiratory pool assays; i.e.
the homozygous diploid (HD) deletion pool in ethanol-,
glycerol-, or lactate-containing media (YPE, YPG, and
YPL), and the respiratory-deficient (RD) deletion pool
in ethanol-containing medium (YPE*). The majority of
strains carry two tags that hybridize to the array, an
“uptag” and a “downtag” [30]. From each array, we ex-
tracted the fluorescence intensity values for every uptag
and downtag associated with the 5050 strains in the HD
pool, or in the case of the RD pool, the up- and downtags
associated with the 331 strains in that pool (Additional
file 2: Table S1). In total, this amounted to 9937, and
675 tags, respectively. The number of tags is not exactly
twice the number of strains because some strains con-
tain only one tag. These raw fluorescence values were
then log2-transformed, and quantile-normalized using the
normalize.quantiles function of the preprocessCore pack-
age in R. Quantile normalization was performed on four
separate groups of tags; uptags from the HD pool samples,
downtags from the HD pool samples, uptags from the RD
pool samples, and downtags from the RD pool samples.
Eight experimental conditions (i.e. the four respiratory
pool assays +/− CuSO4) were performed in triplicate, and
from this set of triplicate measurements, we calculated themean of the normalized fluorescence value for every tag.
For each of the four respiratory pool assays, the mean
values from CuSO4-untreated samples were then subtracted
from the mean values of the CuSO4-treated samples. This
value is the CRS. In cases where a strain contained two
tags (i.e. the vast majority of strains), the CRS was de-
rived from that tag having the greatest difference between
Cu-untreated and -treated samples (i.e. the maximum
absolute value of the Δmeans for the uptag and down-
tag). A moderated t-statistic was used to define differential
effects of Cu-treatment in the four respiratory pools using
the R package LIMMA [78,79], and the derived p-values
were further converted to q-values using Benjamini &
Hochberg False Discovery Rate (FDR) correction [80]. 105
strains that exhibited a significant (q-value < 0.05) and large
(CRS > 1.5) response to copper in at least one of the four
respiratory pool assays (YPG, YPL, YPE, YPE*) were de-
fined as having an increased Cu-boost, and 79 strains that
had a significant (q-value < 0.05) and small (CRS < −1.5) re-
sponse to copper in at least one of these assays were de-
fined as having a decreased Cu-boost. All instances where
these criteria are met are illustrated by the filled circles in
Additional file 1: Figure S3 and S4. The complete list of
CRSs is provided in Additional file 2: Table S1. CEL files
are available via the NCBI's Gene Expression Omnibus
[35] under accession number GSE47175.
Hierarchical clustering
For the cluster analysis in Figure 2B, we calculated the
Cu-induced fold change of the 184 (79 + 105) strains
identified above, in each of the 12 individual replicate
experiments involving the HD pool (YPE, YPG, YPL,
and YPD), and applied hierarchical clustering to these data.
Cu-induced fold change was calculated as (log2 (YPx +
Cu)/(YPx-Cu)mean), where x is one of the 4 carbon sources
(ethanol, glycerol, lactate, dextrose) tested. Fold changes of
uptag and downtag were averaged. Clustering along both
experiment and gene axes was performed on these values
using the TIBCO Spotfire software platform.
GO term enrichment analysis
To identify enriched Gene Ontology terms among the
genes that were identified in this study as enhancing or
diminishing the response to copper we used the Bio-
logical Networks Gene Ontology plugin (BiNGO, version
2.4.4) for Cytoscape (version 2.8.3). Both gene lists (con-
sisting of 93 and 73 open-reading frames, respectively),
were analyzed separately using a Hypergeometric test
with Benjamini & Hochberg False Discovery Rate (FDR)
correction and a significance level of < 0.05. As a refer-
ence set we used the list of 4913 unique open-reading
frames represented in the complete pool of 5050 homo-
zygous deletion strains. We applied a force-directed lay-
out to minimize the number of crossing edges and to
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based on the degree of significance of overrepresentation.
Uncolored nodes are not overrepresented, but they are the
parents of overrepresented categories further down. The
yellow and orange nodes represent terms with significant
enrichment, with darker orange representing a higher de-
gree of significance, as shown by the color legend panel in
Figures 2C and Additional file 1: Figure S6. The size of
each node is proportional to the number of genes with
that term in the query set.
Availability of supporting data
The array data supporting the results of this article have
been deposited in NCBI's Gene Expression Omnibus [35]
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